ADVANCES IN CANCER GENOMICS, BIOMARKER TESTING AND PRECISION DIAGNOSTICS

Advances in cancer genomics, biomarker testing, and precision diagnostics are transforming cancer care by enabling more personalized and effective treatments. These fields use technologies like next-generation sequencing, liquid biopsies, and artificial intelligence to identify specific genetic mutations, proteins, and other biomarkers that guide tailored therapies and improve outcomes. This is a shift from traditional, one-size-fits-all approaches to a more precise model of care, with liquid biopsies offering a less invasive way to monitor cancer and identify targets.